See more : FERMENTA BIOTECH LIMITED (FERMENTA.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Else Nutrition Holdings Inc. (BABYF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Else Nutrition Holdings Inc., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
You may be interested
- Raval ACS Ltd. (RVL.TA) Income Statement Analysis – Financial Results
- Luceco plc (LUCE.L) Income Statement Analysis – Financial Results
- North Industries Group Red Arrow Co., Ltd (000519.SZ) Income Statement Analysis – Financial Results
- Latin Resources Limited (LRS.AX) Income Statement Analysis – Financial Results
- KRM22 Plc (KRM.L) Income Statement Analysis – Financial Results
Else Nutrition Holdings Inc. (BABYF)
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. engages in the development, production, and sale of food and nutrition products for infants, toddlers, children, and adults in North America and Israel. It offers baby snacks; baby feeding accessories, such as feeding bottles and teats; plant-based baby formula products; toddler, children, and adult nutrition products; and complementary food products. The company also offers its products through online. Else Nutrition Holdings Inc. is headquartered in Tel Aviv-Yafo, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.36M | 8.53M | 4.69M | 1.48M | 554.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 9.45M | 7.22M | 3.94M | 984.00K | 303.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -85.00K | 1.31M | 743.00K | 498.00K | 251.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -0.91% | 15.37% | 15.85% | 33.60% | 45.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 2.56M | 2.56M | 1.97M | 1.11M | 261.00K | 0.00 | 0.00 | 964.00 | 889.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 7.27M | 9.71M | 7.96M | 5.40M | 2.12M | 103.10K | 0.00 | 53.16K | 84.34K | 109.93K | 27.87K | 114.93K |
| Selling & Marketing | 4.38M | 5.96M | 6.49M | 1.93M | 284.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.65M | 15.66M | 14.45M | 7.33M | 2.40M | 103.10K | 50.61K | 53.16K | 84.34K | 109.93K | 27.87K | 114.93K |
| Other Expenses | -14.30M | 3.62M | 2.05M | 1.08M | 595.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | -85.00K | 21.85M | 18.46M | 9.52M | 3.26M | 108.60K | 50.61K | 54.13K | 85.23K | 109.93K | 27.87K | 114.93K |
| Cost & Expenses | 25.61M | 29.06M | 22.41M | 10.50M | 3.56M | 108.60K | 50.61K | 54.13K | 85.23K | 109.93K | 27.87K | 114.93K |
| Interest Income | 62.00K | 74.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 170.00 | 1.47K | 506.00 |
| Interest Expense | 63.00K | 13.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 379.00K | 496.00K | 384.00K | 193.00K | 74.00K | 306.86K | 52.52K | 22.82K | 0.00 | 0.00 | 265.61K | 0.00 |
| EBITDA | -15.17M | -17.11M | -17.15M | -8.70M | -2.81M | 0.00 | -50.61K | -54.13K | -85.23K | -109.93K | 237.74K | -114.93K |
| EBITDA Ratio | -162.02% | -269.26% | -713.42% | 422.60% | -101.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -16.25M | -23.46M | -33.82M | 6.07M | -638.00K | -109.35K | -50.61K | -54.13K | -85.23K | -109.93K | -27.87K | -114.93K |
| Operating Income Ratio | -173.58% | -275.08% | -721.61% | 409.58% | -115.16% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 640.00K | 1.84M | 15.29M | -24.10M | -2.37M | 1.51K | 0.00 | 0.00 | 0.00 | 170.00 | -264.13K | 506.00 |
| Income Before Tax | -15.61M | -17.61M | -1.62M | -24.10M | -5.38M | -107.84K | -50.61K | -54.13K | -85.23K | -109.76K | -292.00K | -114.42K |
| Income Before Tax Ratio | -166.75% | -206.57% | -34.52% | -1,626.45% | -970.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -5.84M | -16.10M | 15.09M | 2.37M | -307.61K | -51.76K | -22.81K | 0.00 | 0.00 | -1.47K | 0.00 |
| Net Income | -15.61M | -11.77M | 14.48M | -39.19M | -7.75M | -107.84K | -50.61K | -54.13K | -85.23K | -109.76K | -292.00K | -114.42K |
| Net Income Ratio | -166.75% | -138.06% | 309.02% | -2,644.47% | -1,398.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.13 | -0.11 | 0.15 | -0.49 | -0.15 | -0.10 | -0.05 | -0.05 | -0.19 | -0.37 | -0.99 | -2.00 |
| EPS Diluted | -0.12 | -0.11 | 0.14 | -0.48 | -0.15 | -0.10 | -0.05 | -0.05 | -0.19 | -0.37 | -0.99 | -2.00 |
| Weighted Avg Shares Out | 116.78M | 108.68M | 97.46M | 80.35M | 50.40M | 1.05M | 1.04M | 1.04M | 439.32K | 294.00K | 294.00K | 57.28K |
| Weighted Avg Shares Out (Dil) | 129.78M | 108.68M | 100.52M | 81.37M | 50.40M | 1.05M | 1.04M | 1.04M | 439.32K | 294.00K | 294.00K | 57.28K |
Else Nutrition announces highly favorable results from independent pilot study; expands on Amazon; gets conditional approval for listing on the Toronto Stock Exchange
Else Nutrition Holdings Inc (OTCQX:BABYF, TSX-V:BABY) has announced highly favorable results from an independent pilot study conducted with US mom customers of its Plant-Based Nutrition for Toddlers and Kids. Conducted independently by third party global market research firm, GetWizer, the...
Else Nutrition announces highly favorable results from independent pilot study of customers for its Plant-Based Nutrition for Toddlers and Kids
Else Nutrition Holdings Inc (OTCQX:BABYF, TSX-V:BABY) has announced highly favorable results from an independent pilot study conducted with US mom customers of its Plant-Based Nutrition for Toddlers and Kids. Conducted independently by third party global market research firm, GetWizer, the...
Else Nutrition updates on key sales growth drivers for 2022
Else Nutrition Holdings Inc (OTCQX:BABYF, TSX-V:BABY) continues its bid to become a global brand in the health nutrition space, the firm said, as it outlined key sales growth drivers for 2022. The Israel-based company develops plant-based food and nutrition products for infants,...
Else Nutrition expands product offerings on iHerb to include plant-based kids shake mix
Else Nutrition Holdings Inc said it will be expanding its current line of plant-based nutrition products with US-based, international online retailer iHerb Inc with the addition of Else's plant-based kids shake mix. The company noted the development is expected to...
Else Nutrition enjoys strong performance on Amazon; outpacing other brands in the same category
Else Nutrition Holdings Inc said it has enjoyed a strong performance on the Amazon platform with sales growing approximately 10% month-on-month over the past 6 months. According to recent Amazon data, Else Nutrition has outpaced growth by brands in the same category each month, the...
Else Nutrition is offering plant-based nutrition alternatives for babies and toddlers
Every year thousands of new parents struggle with feeding allergic or food-sensitive babies and toddlers. Lactose intolerance in various degrees can cause anything from stomach discomfort and gas to more serious health concerns that can lead to the hindrance of development and growth.
Else Nutrition to raise over $15M for plant-based toddler nutrition product expansion efforts
Else Nutrition Holdings Inc announced plans to raise up to $15.05 million via a marketed public offering of 7 million units priced at $2.15 per unit. The Vancouver-based company — dedicated to producing plan-based food products for infants and adults — will offer...
Else Nutrition successfully completes first production trial run of its novel plant-based infant formula
Else Nutrition Holdings Inc. announced that it has successfully completed the first commercial trial run of its patented, plant-based Infant Formula for age 0-12 months as the company continues its path towards regulatory approval.
Else Nutrition Successfully Completes First Production Trial Run of its Novel, Plant-Based Infant Formula
Development brings Company a step closer to bringing first-of-its-kind product to $90 Billion Global Infant Formula Market Development brings Company a step closer to bringing first-of-its-kind product to $90 Billion Global Infant Formula Market
Else Nutrition to expand to Walmart.com in November, adding Kids plant-based shakes to listings
Else Nutrition Holdings Inc said that it will proceed with an online distribution agreement with Walmart.com by November 2021 with the launch of its Plant-Based Complete Nutrition product range for Toddlers and Kids. The Israel-based food and nutrition company announced the Walmart.com...
Source: https://incomestatements.info
Category: Stock Reports